Skip to main content
logo
CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
14.00
+0.25 (1.82%)
At close: Feb 12, 2026

CRISM Therapeutics Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
--0.05---
Other Revenue
0.030.03----
Revenue
0.030.030.05---
Revenue Growth (YoY)
-44.44%-44.44%----
Cost of Revenue
0.0100.03---
Gross Profit
0.020.020.01---
Selling, General & Admin
1.320.720.141.851.322.26
Research & Development
0.170.170.03---
Operating Expenses
1.510.90.181.851.322.26
Operating Income
-1.49-0.88-0.17-1.85-1.32-2.26
Interest Expense
--0.01-0.03---0.01
Interest & Investment Income
-----0.15
Currency Exchange Gain (Loss)
-----00
Other Non Operating Income (Expenses)
------0.07
EBT Excluding Unusual Items
-1.49-0.89-0.2-1.85-1.32-2.18
Asset Writedown
-----0.31
Other Unusual Items
-0.3--0.32--0.08
Pretax Income
-1.49-0.59-0.2-2.16-1.32-1.95
Income Tax Expense
---0.01---
Earnings From Continuing Operations
-1.49-0.59-0.2-2.16-1.32-1.95
Earnings From Discontinued Operations
-0.04-0.01--0.340.43-
Net Income
-1.52-0.61-0.2-2.5-0.89-1.95
Net Income to Common
-1.52-0.61-0.2-2.5-0.89-1.95
Shares Outstanding (Basic)
45320997
Shares Outstanding (Diluted)
45320997
Shares Change (YoY)
39.18%201033.86%-99.82%0.85%28.82%45.57%
EPS (Basic)
-0.03-0.02-12.25-0.29-0.10-0.29
EPS (Diluted)
-0.03-0.02-12.25-0.29-0.10-0.29
Free Cash Flow
-1.33-0.93-0.1-2.92-1.67-2.02
Free Cash Flow Per Share
-0.03-0.03-6.13-0.34-0.19-0.30
Gross Margin
72.00%84.00%28.89%---
Operating Margin
-5952.00%-3520.00%-377.78%---
Profit Margin
-6096.00%-2428.00%-435.56%---
Free Cash Flow Margin
-5336.00%-3732.00%-217.78%---
EBITDA
-1.47-0.86-0.15-1.62-1.12-2.26
D&A For EBITDA
0.020.020.020.230.20
EBIT
-1.49-0.88-0.17-1.85-1.32-2.26
Source: S&P Global Market Intelligence. Standard template. Financial Sources.